NOESIS

NOESIS will provide health professionals involved in research and cure of cardiac and cardiovascular diseases, with an easily and from everywhere accessible Knowledge Management system equipped with a Decision Support System tool, to be used for supporting them in their clinical decisions both in emergency situations and during their daily work with patients.

Medical knowledge is inherently complex and uncertain. Medical experts may provide different interpretations for symptoms since all of them also depend on a given context and most of them are established by statistical utilisation. In the United Kingdom a pilot study found a 10% adverse event rate, of which half were preventable.

NOESIS will develop an intelligent environment that enables ubiquitous management of citizens' health status and to assist health professionals in coping with some major challenges, risk management and the integration into clinical practice of advances in health knowledge. The selected clinical domain addressed by the project will be Cardiology.

In particular NOESIS will contribute to:

  • Reduce the uncertainty in diagnosis of diseases, focusing on cardiovascular diseases.
  • Support the process of diagnosis and treatment by reducing errors and minimising risks.
  • Enhance the quality of medical care provided through the use of decision support mechanisms.
  • Provide methods for establishing trust and confidence of users towards information sources.

For further information, please visit:
http://www.noesis-eu.org

Project co-ordinator:
Boehringer Ingelheim Italia S.p.A.

Partners:

  • Boehringer Ingelheim Italia S.P.A. (IT)
  • Siemens S.A. (ES)
  • Airial Conseil (FR)
  • Universite Joseph Fourier Grenoble (Timc Laboratory) (FR)
  • Centre Hospitalier Regional Universitaire de Grenoble (FR)
  • Sesa Ltd. (AT)
  • University of Ioannina (GR)
  • Hellenic Cardiological Society (GR)
  • Medisell Co. Ltd. (CY)
  • M.R.I. Lefkothea Medical Services (CY)
  • Business Flow Consulting (FR)

Timetable: from 01/04 – to 12/06

Total cost: € 7.715.793

EC funding: € 4.400.000

Instrument: IP

Project Identifier: IST-2002-507960

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...